Skip to content

FlexLab

by Inpeco SA

Ref FLXModel TLA

FlexLab (FLX) is a specimen processing instrument IVD (EU IVDR Class A; FDA Class II; FDA product code CEM, Electrode, Ion Specific, Potassium) made by Inpeco SA, registered in EUDAMED on 23 May 2023 (Basic UDI-DI 764017234TLAKW), cleared under FDA 510(k) K121012 on 31 Aug 2012 and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 07640172340004), active as of 22 Oct 2026. 24 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

17 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K121012

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number764017234TLAKW Basic UDI-DI 07640172340004UDI-DIDate23 May 2023RegisteredStatusActive
United StatesGUDID listing GUDID Number07640172340004 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK121012 Date31 Aug 2012DecidedStatusActive

Official records

From the FDA record

Device description
The FlexLab Automation is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The system consolidates multiple Analytical instruments into a unified workstation.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 764017234TLAKW registered 23 May 2023 Active
  • FDA 510(k) K121012 decided 31 Aug 2012 Active
  • FDA GUDID UDI-DI 07640172340004 listed 24 Sep 2016 Listed

Recalls

33 recalls · 17 ongoing · FDA

    • Ongoing Z-0595-2026 FDA Class II initiated 30 Oct 2025

    The Aliquoter Module (mALX) may generate secondary sample tubes without labels or with mismatched labels which may result in delayed results or erroneous results. This error occurs if the operators open the printer head of mALX to perform error recoveries or maintenance procedures and do not empty the printer tubes buffer to remove all the secondary sample tubes.

    • Ongoing Z-0596-2026 FDA Class II initiated 30 Oct 2025

    The Aliquoter Module (mALX) may generate secondary sample tubes without labels or with mismatched labels which may result in delayed results or erroneous results, this error occurs if the operators open the printer head of mALX to perform error recoveries or maintenance procedures and do not empty the printer tubes buffer to remove all the secondary sample tubes

    • Ongoing Z-0107-2026 FDA Class II initiated 3 Sep 2025

    The FlexLab X System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

    • Ongoing Z-0106-2026 FDA Class II initiated 3 Sep 2025

    The FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.

    • Ongoing Z-0560-2024 FDA Class II initiated 3 Nov 2023

    Firmware of the Interface Module with Roche Cobas 8000 and Cobas PRO (CO8 IM) may lead to a delayed sample tube processing.

  • 5 recalls, same reason

    • Ongoing Z-1562-2023 FDA Class II initiated 10 Mar 2023
    • Ongoing Z-1563-2023 FDA Class II initiated 10 Mar 2023
    • Ongoing Z-1561-2023 FDA Class II initiated 10 Mar 2023
    • Ongoing Z-1559-2023 FDA Class II initiated 10 Mar 2023
    • Ongoing Z-1560-2023 FDA Class II initiated 10 Mar 2023

    Firmware versions have the potential to mis-associate sample IDs leading to incorrect results or delayed sodium, potassium, and chloride patient results. Falsely increased or decreased electrolytes can lead to either inappropriate treatment of normal results, or failure to treat abnormal results resulting in abnormal levels. Abnormal potassium levels can result in weakness, polyuria, ileus, psychiatric disturbances, cardiac arrhythmias, respiratory depression, and death. Abnormal sodium levels can result in CNS disturbances and disturbances of water balance. Abnormal chloride levels can lead to acid base disturbances which can lead to respiratory and cardiac compromise. The event may occur only if all the following conditions occurs in few milliseconds timeframe: - The module is releasing a sample tube (Tube A) just placed into the carrier - Another sample tube (Tube B) is erroneously not diverted into the module buffer lane due to a malfunction of the divert gate Only in this specific scenario, the Tube A may be released by the module as Tube B due to a miscommunication between the module firmware and the Automation software without any error message. The Automation System loses the traceability of Tube A. It manages both Tube A (incorrectly identified as Tube B) and the real Tube B according to the test orders not performed yet on Tube B. Inpeco has released a Technical Service Bulletin with the procedure to correctly update the firmware. The firmware upgrade will be performed by Field Service Engineers. A CAPA (Corrective Action Preventive Action) has been opened to deeply investigate the root cause and identify possible process lack in order to avoid reoccurrences.

    • Ongoing Z-0087-2022 FDA Class II initiated 10 Sep 2021

    The Firmware (FW) of the Automation System Interface Module to ADVIA Centaur XP/XPT may lead to an incorrect association of test results to sample ID. Improper management of the sample may bring an incorrect patient result.

  • 3 recalls, same reason

    • Ongoing Z-1889-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012
    • Ongoing Z-1888-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012
    • Ongoing Z-1887-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012

    The FlexLab Centrifuge Module loading algorithm may lead to unbalanced loads which could damage the centrifuge.

    • Ongoing Z-2198-2020 FDA Class II initiated 7 Apr 2020

    Potential for discrepant patient results due to a potential for the primary sample tube to be diluted. In certain firmware versions, in case a Clot Detection error (error code E0E0 or 13E0) is generated during the sample aspiration the current error recovery procedure dispenses 2/3 of sample volume back into the Primary Tube. Evidence from the field showed that in case of Clot Detection error, this management may lead to the dilution of the Primary Tube with the distilled water of the hydraulic circuit of the Aliquoter Module.

  • 2 recalls, same reason

    • Ongoing Z-2199-2020 FDA Class II initiated 7 Apr 2020
    • Ongoing Z-2200-2020 FDA Class II initiated 7 Apr 2020

    In certain firmware versions, in case a Clot Detection error (error code E0E0 or 13E0) is generated during the sample aspiration the current error recovery procedure dispenses 2/3 of sample volume back into the Primary Tube. Evidence from the field showed that in case of Clot Detection error, this management may lead to the dilution of the Primary Tube with the distilled water of the hydraulic circuit of the Aliquoter Module.

  • 3 recalls, same reason

    • Terminated Z-2975-2020 FDA Class II initiated 7 Aug 2020
    • Terminated Z-2974-2020 FDA Class II initiated 7 Aug 2020
    • Terminated Z-2973-2020 FDA Class II initiated 7 Aug 2020

    Firmware of the Sysmex XN-9000/XN-9100 Interface Module (IM) and of the Track to Rack Module has the potential to mis-associate sample IDs leading to incorrect results or delayed results

  • 3 recalls, same reason

    • Terminated Z-0432-2021 FDA Class II initiated 14 Jul 2020
    • Terminated Z-0434-2021 FDA Class II initiated 14 Jul 2020
    • Terminated Z-0433-2021 FDA Class II initiated 14 Jul 2020

    When a Clot Detection Error is generated during the sample aspiration from the Primary Sample Tube the aspirated volume is dispensed into the first empty Secondary Sample Tube. This Secondary Sample Tube is flagged with error 2132 or 1442 and sent to IOM Priority Output Racks to be manually managed. The current error message associated to error 2132 or 1442 recommends that the operator manages these Secondary Sample Tubes according to Laboratory Practice, but it does not clarify that these Secondary Sample Tubes may be diluted with water from the hydraulic circuit of the Aliquoter Module this may lead to reporting of erroneous results if the diluted sample is used for testing.

  • 2 recalls, same reason

    • Terminated Z-2115-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012
    • Terminated Z-2114-2020 FDA Class II initiated 7 Apr 2020

    The sensors which activate the safety switches may be affected by delayed activation. In 1% of the cases, the response delay can be up to a maximum delay of 2 seconds, instead of 40ms expected by design.

  • 2 recalls, same reason

    • Terminated Z-2003-2020 FDA Class II initiated 7 Apr 2020
    • Terminated Z-2004-2020 FDA Class II initiated 7 Apr 2020

    When analyzer sample carousel lid remains open or manual process is too long, Module timeout expiry errors could occur causing cross contamination of samples.

  • 3 recalls, same reason

    • Terminated Z-2141-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012
    • Terminated Z-2140-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012
    • Terminated Z-2142-2020 FDA Class II initiated 7 Apr 2020 on shared 510(k) K121012

    The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

    • Terminated Z-0361-2019 FDA Class II initiated 24 Aug 2018 on shared 510(k) K121012

    The firm has identified customer sites where there are modules on which the safety pacemaker label is missing. The information regarding the label included in the Operations Manual has been updated to specify that: 1) the risk of a pacemaker malfunction applies to anyone with a pacemaker who may work on these modules; and 2) the minimum safety distance has been increased to 200 mm (7.87") from the transport mechanisms. Any person with a pacemaker must not get closer than this distance from the modules axes.

    • Terminated Z-1798-2018 FDA Class II initiated 13 Feb 2018 on shared 510(k) K121012

    Module may freeze without generating user warning. There is a potential risk in delay of sample processing, leading to delayed delivery of test results to patients.

    • Terminated Z-0587-2017 FDA Class II initiated 4 Oct 2016

    Inpeco received several notifications from the field about burnt schuko sockets. The customers reported that some smoke was seen coming from the damaged sockets.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

36 dated events

  1. Recall initiated FDA recalls Z-1563-2023
  2. Recall initiated FDA recalls Z-1561-2023
  3. Recall initiated FDA recalls Z-1559-2023
  4. Recall initiated FDA recalls Z-1560-2023
  5. Registered EUDAMED 764017234TLAKW
  6. Recall initiated FDA recalls Z-0560-2024
  7. Recall initiated FDA recalls Z-0107-2026
  8. Recall initiated FDA recalls Z-0106-2026
  9. Recall initiated FDA recalls Z-0595-2026
  10. Recall initiated FDA recalls Z-0596-2026

26 earlier events are in the sections above.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Generic name
Specimen processing instrument IVD
Device name
Inpeco Total Laboratory Automation
Model / reference
TLA, FLX
Primary DI / UDI-DI
07640172340004
Basic UDI-DI
764017234TLAKW
Direct marketing DI
07640172340004
510(k) Number
FDA product code
CEM
EMDN code
W02060101 Automated systems for the management of pre and post-analysis
GMDN term
Specimen processing instrument IVD
Device class
Class A EUDAMED
Class II GUDID
Regulation number
862.1600
EU registration type
Standard device
EU market of registration
Finland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class A
GUDID
Class II

Device class is stated on each registry's own scale: Class A in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
CH-MF-000017833
Authorised representative
QbD RepS BV BE-AR-000000040

Similar devices in this category

Other devices filed under AUTOMATED SYSTEMS FOR THE MANAGEMENT OF PRE AND POST-ANALYSIS.

Other devices from Inpeco SA

See all devices from Inpeco SA →

Properties

  • Professional testing
  • IVD instrument
  • Serial number
  • Manufacturing date
Other properties (22, all answered No)